PRESS RELEASE published on 05/10/2023 at 07:30, 1 year 6 months ago STEMMER IMAGING continues strong growth with double-digit increases in Revenue and EBITDA in Q1 2023
PRESS RELEASE published on 03/31/2023 at 07:30, 1 year 7 months ago STEMMER IMAGING publishes Annual Report 2022: excellent revenue and earnings growth with positive outlook for 2023. Increase of medium-term guidance for EBITDA margin to 15–19%
PRESS RELEASE published on 03/06/2023 at 17:04, 1 year 8 months ago EQS-Adhoc: STEMMER IMAGING proposes increase of the regular dividend as well as payment of a special dividend
PRESS RELEASE published on 02/23/2023 at 07:30, 1 year 8 months ago STEMMER IMAGING confirms growth path in 2022 with clear double-digit growth rates and significantly increased EBITDA margin
PRESS RELEASE published on 01/31/2023 at 08:00, 1 year 9 months ago STEMMER IMAGING is awarded silver certification in EcoVadis sustainability rating
PRESS RELEASE published on 01/17/2023 at 07:30, 1 year 10 months ago STEMMER IMAGING confirms growth prospects with record order in the Artificial Vision segment
Published on 11/21/2024 at 14:00, 11 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 11 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 11 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 41 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 36 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 56 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 13 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 51 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 26 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 26 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
